Specific interaction of conformational polypeptides derived from HIV gp120 with human T lymphocyte CD4 receptor

Area of Science:

• Virology
• Immunology
• Biochemistry

Background:

• The C4 domain of human immunodeficiency virus (HIV) glycoprotein 120 (gp120) is critical for binding to the CD4 receptor, initiating viral entry.
• Understanding the molecular basis of this interaction is key to developing effective HIV therapeutics and vaccines.

Purpose of the Study:

• To investigate whether cross-linked peptides (peptomers) derived from HIV C4 domains can mimic the gp120 protein's interaction with the CD4 receptor.
• To identify the specific components and structural features of C4 peptomers responsible for CD4 binding.

Main Methods:

• Preparation of cross-linked peptomers from HIV-1 and HIV-2 C4 domain sequences.
• Utilized a novel protein-binding assay to assess the interaction between C4 peptomers and recombinant soluble CD4 protein.
• Tested control peptomers (Poly V3 MN, Poly NINA) and monomeric peptides for CD4 binding to ensure specificity.

Main Results:

• All polymeric components of HIV-1 C4 peptomers demonstrated binding to soluble CD4 protein.
• HIV-2 C4 peptomers showed CD4 binding only in constituents larger than trimers.
• CD4 binding was specific to HIV C4 peptomers, with no binding observed for control peptomers or monomeric peptides.
• Higher alpha-helical content in peptomers correlated with successful CD4 binding compared to monomeric peptides.

Conclusions:

• The secondary structure, specifically alpha-helical conformation, is a critical determinant for CD4 binding by HIV C4 peptomers.
• These findings provide a more defined molecular understanding of the gp120-CD4 interaction.
• The results have implications for designing novel HIV vaccines and therapeutics targeting the initial viral attachment step.